Home › Funds › BENEDICT FINANCIAL ADVISORS INC › ABT
BENEDICT FINANCIAL ADVISORS INC position in ABT
ABBOTT LABORATORIES · Health Care
BENEDICT FINANCIAL ADVISORS INC reported holding 34,869 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$3.4M, representing 0.68% of its reported portfolio and ranking #50 among its reported holdings. BENEDICT FINANCIAL ADVISORS INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-10-09 · Source: SEC EDGAR Form 13F-HR
How BENEDICT FINANCIAL ADVISORS INC's ABT position evolved
BENEDICT FINANCIAL ADVISORS INC first disclosed a stake in ABT in Q3 2023 at 34,998 shares (US$3.4M). The position peaked in Q2 2025 at 32,994 shares, worth US$4.5M. Across 13 filings, BENEDICT FINANCIAL ADVISORS INC increased the stake 3 time(s), trimmed it 5 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 34,869 shares valued at US$3.4M — an increase of 376 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 35.00K | $3.39M | New |
| Q4 2023 | 34.52K | $3.80M | Reduce |
| Q1 2024 | 34.23K | $3.89M | Reduce |
| Q2 2024 | 34.08K | $3.54M | Hold |
| Q3 2024 | 33.64K | $3.83M | Reduce |
| Q4 2024 | 33.49K | $3.79M | Hold |
| Q1 2025 | 33.07K | $4.39M | Reduce |
| Q2 2025 | 32.99K | $4.49M | Hold |
| Q3 2025 | 32.46K | $4.35M | Reduce |
| Q4 2025 | 32.33K | $4.05M | Hold |
| Q1 2026 | 32.70K | $3.36M | Add |
| Q2 2026 | 34.49K | $3.13M | Add |
| Q3 2026 | 34.87K | $3.45M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ABT and 13F data
ABT (ABBOTT LABORATORIES) is a Health Care company. 20 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ABT
- Vanguard Group 175.56M sh · $22.00B · Q4 2025
- Charles Schwab Investment Management 59.67M sh · $5.41B · Q2 2026
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC 59.67M sh · $5.41B · Q2 2026
- Sixth Street Partners Management Company, L.P. 59.67M sh · $5.41B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital Research Global Investors 36.91M sh · $3.35B · Q2 2026
- Capital International Investors 34.65M sh · $3.15B · Q2 2026
- Deutsche Bank AG 16.71M sh · $1.52B · Q2 2026
More on BENEDICT FINANCIAL ADVISORS INC
FAQ
How long has BENEDICT FINANCIAL ADVISORS INC held ABT?
BENEDICT FINANCIAL ADVISORS INC has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is BENEDICT FINANCIAL ADVISORS INC's current position in ABT?
As of Q3 2026, BENEDICT FINANCIAL ADVISORS INC holds 34.87K shares of ABT (ABBOTT LABORATORIES), valued at $3.45M, representing 0.68% of its reported portfolio and ranking #50.
Has BENEDICT FINANCIAL ADVISORS INC been buying or selling ABT?
In the latest 13F filing (Q3 2026), BENEDICT FINANCIAL ADVISORS INC increased its position in ABT. The position peaked in Q2 2025 at 32.99K shares.
Which other funds hold ABT?
Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 20 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.